These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24307836)

  • 1. Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation.
    Broxmeyer HE
    Korean J Intern Med; 2013 Nov; 28(6):639-45. PubMed ID: 24307836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DPP4/CD26 and dmPGE₂ treatment enhances engraftment of mouse bone marrow hematopoietic stem cells.
    Broxmeyer HE; Pelus LM
    Blood Cells Mol Dis; 2014; 53(1-2):34-8. PubMed ID: 24602918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.
    O'Leary H; Ou X; Broxmeyer HE
    Curr Opin Hematol; 2013 Jul; 20(4):314-9. PubMed ID: 23594692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.
    Zebedin-Brandl E; Themanns M; Kazemi Z; Nasrollahi-Shirazi S; Mussbacher M; Heyes E; Meissl K; Prchal-Murphy M; Strohmaier W; Krumpl G; Freissmuth M
    J Mol Med (Berl); 2020 Feb; 98(2):233-243. PubMed ID: 31872285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types.
    Ou X; O'Leary HA; Broxmeyer HE
    Blood; 2013 Jul; 122(2):161-9. PubMed ID: 23637126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
    Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
    Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine - Review.
    Torrecillas-Baena B; Gálvez-Moreno MÁ; Quesada-Gómez JM; Dorado G; Casado-Díaz A
    Stem Cell Rev Rep; 2022 Jan; 18(1):56-76. PubMed ID: 34677817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
    Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.
    Broxmeyer HE
    Ann N Y Acad Sci; 2012 Aug; 1266(1):151-60. PubMed ID: 22901266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis.
    Broxmeyer HE; Hoggatt J; O'Leary HA; Mantel C; Chitteti BR; Cooper S; Messina-Graham S; Hangoc G; Farag S; Rohrabaugh SL; Ou X; Speth J; Pelus LM; Srour EF; Campbell TB
    Nat Med; 2012 Dec; 18(12):1786-96. PubMed ID: 23160239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
    Klemann C; Wagner L; Stephan M; von Hörsten S
    Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
    Christopherson KW; Hangoc G; Broxmeyer HE
    J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An expanded role for dipeptidyl peptidase 4 in cell regulation.
    Ropa J; Broxmeyer HE
    Curr Opin Hematol; 2020 Jul; 27(4):215-224. PubMed ID: 32487805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
    Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation.
    Campbell TB; Broxmeyer HE
    Front Biosci; 2008 Jan; 13():1795-805. PubMed ID: 17981668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Hematopoietic Chemokine Effects In Vitro and In Vivo by DPP-4/CD26.
    Broxmeyer HE; Capitano M; Campbell TB; Hangoc G; Cooper S
    Stem Cells Dev; 2016 Apr; 25(8):575-85. PubMed ID: 26943017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice.
    Campbell TB; Hangoc G; Liu Y; Pollok K; Broxmeyer HE
    Stem Cells Dev; 2007 Jun; 16(3):347-54. PubMed ID: 17610364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice.
    Christopherson KW; Paganessi LA; Napier S; Porecha NK
    Stem Cells Dev; 2007 Jun; 16(3):355-60. PubMed ID: 17610365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26/DPP4 - a potential biomarker and target for cancer therapy.
    Enz N; Vliegen G; De Meester I; Jungraithmayr W
    Pharmacol Ther; 2019 Jun; 198():135-159. PubMed ID: 30822465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
    Juillerat-Jeanneret L
    J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.